Last year concluded in a hive of activity at the Patent Trial and Appeal Board (PTAB), seeing guidance memorandums, modifications to the director review process, and policy formation via the designation of influential opinions and director review resolutions. It reasonates that this flux will have a profound impact on 2024. Attorneys from esteemed law firm, Finnegan, predict six key areas to focus on, including potential adjustments to the director review process and the first ever case hitting the Appeals Review Panel. There’s a clearly defined direction the PTAB is heading in.
Among the important points noted by attorneys was the impact of guidance memorandums, which played a pivotal role last year and are predicted to continue to drive policy and process changes at the PTAB this year. The interplay between these guidelines and the review process, particularly concerning the director review process, has sparked noteworthy discussion and is likely to remain a focal area.
Furthermore, the director review process itself is predicted to undergo additional changes. Last year witnessed a shift in how the PTAB operates regarding this process, and further evolution in 2024 is expected by industry insiders. Notably, the initiation of the first case to be seen by the Appeals Review Panel heralds a potential new dimension to PTAB rulings.
These observations are just the tip of the iceberg; there’s an undercurrent of factors at play set to significantly shape the PTAB spectrum in 2024. The original publication by Law360 offers a wealth of insight and is available here.